Latest News and Press Releases

Dallas, TX, March 24, 2025 (GLOBE NEWSWIRE) -- Spark Biomedical, a leader in wearable neurostimulation technology, has completed enrollment for its pivotal phase II clinical trial, offering hope to...

Dublin, Jan. 31, 2025 (GLOBE NEWSWIRE) -- The "Wearable Bioelectronic Skin Patches - Global Strategic Business Report" has been added to ResearchAndMarkets.com's offering.The global market for...

SAN FRANCISO, Dec. 11, 2024 (GLOBE NEWSWIRE) -- FemPulse™ announced today Investigational Device Exemption (IDE) approval from the U.S. Food and Drug Administration (FDA) to begin its EVANESCE II...

Dublin, March 08, 2024 (GLOBE NEWSWIRE) -- The "Joint Venture Deals in Pharmaceuticals and Biotechnology 2016-2024" report has been added to ResearchAndMarkets.com's offering.Joint Venture Deals in...

Bredis Healthcare secures KRW 1.7 billion grant for advancing Alzheimer’s disease diagnosis from South Korean government’s Deep Tech TIPS programNovel platform has demonstrated detection of...

Dublin, June 28, 2023 (GLOBE NEWSWIRE) -- The Global Bioelectronic Medicine Markets, 2018-2028 report has been added to ResearchAndMarkets.com's offering.The global bioelectronic medicine market is...

Dublin, Jan. 20, 2023 (GLOBE NEWSWIRE) -- The "Printed Electronics Global Market Report 2022" report has been added to ResearchAndMarkets.com's offering. This report provides strategists,...

Double-blind randomized controlled trial will enroll up to 225 children at UCLA and Seattle Children’s Hospital NeuroSigma will provide Monarch eTNS Systems and funding for long-term follow-up ...

LOS ANGELES, Feb. 22, 2022 (GLOBE NEWSWIRE) -- NeuroSigma, Inc., a bioelectronic medical device company, today announced FDA Breakthrough Device Designation for its Monarch eTNS System® for...

LOS ANGELES, Jan. 11, 2022 (GLOBE NEWSWIRE) -- NeuroSigma, Inc., a bioelectronic medical device company, today announced the promotion of Dr. Colin Kealey to President. NeuroSigma is the developer...